...
首页> 外文期刊>Surgical infections >Risk of Surgical Site Infection in Patients with Asymptomatic Bacteriuria or Abnormal Urinalysis before Joint Arthroplasty: Systematic Review and Meta-Analysis
【24h】

Risk of Surgical Site Infection in Patients with Asymptomatic Bacteriuria or Abnormal Urinalysis before Joint Arthroplasty: Systematic Review and Meta-Analysis

机译:无症状细菌性尿道感染或关节置换术前尿液分析异常的患者发生手术部位感染的风险:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Routine screening and treatment for pre-operative asymptomatic bacteriuria (ASB) before joint arthroplasty are controversial. This systematic review and meta-analysis aimed to evaluate the impact of ASB and other bacterial colonization markers (BCM) observed in abnormal urine analyses, such as positive nitrites, leukocyturia, or positive leukocyte esterase in the risk of surgical site infections (SSIs) of joint arthroplasty patients. Methods: Studies published between 1970 and 2017 that reported data on SSI and prosthetic joint infection (PJI) in patients after joint arthroplasty of the hip, knee, or shoulder with pre-operative ASB or BCM were included. A meta-analysis with random effect model was performed. Results: Eleven studies were included (29,371 patients and 35,323 joints). The main procedures were total hip replacements (53.3%) and the mean follow-up period was 21.5 months, with 12 months being the minimum time of follow-up. A total of 2,400 cases (9.5%) reported pre-operative BCM (15%) or ASB (85%). The proportion of SSI was higher in patients with ASB (2.3% vs. 1.1%) (p0.001) and was related to a higher risk of SSI (odds ratio [OR] 2.89; 95% confidence interval [CI] 1.36-6.17), however, in only six cases (12.7%) was the SSI micro-organism correlated with the urine culture. Finally, antibiotic treatment for ASB did not reduce the SSI risk (OR=0.82; 95% CI 0.34-1.97). Conclusions: Asymptomatic bacteriuria represent a relatively common finding among these patients and is related to a higher risk of SSI. However, the poor microbiologic correlation suggests that ASB could represent a surrogate marker for other conditions correlated with bacterial infection. Therefore, systematic urinalysis screening should be discouraged, whereas a complete risk assessment that considers comorbidities and past medical history should be promoted.
机译:背景:关节置换术前的常规筛查和术前无症状菌尿(ASB)的治疗引起争议。这项系统的审查和荟萃分析旨在评估ASB和其他细菌定殖标记(BCM)在异常尿液分析(如亚硝酸盐,白血球阳性或白细胞酯酶阳性)中的发生对手术部位感染(SSI)风险的影响。关节置换术患者。方法:纳入1970年至2017年发表的研究,该研究报告了术前ASB或BCM进行的髋,膝或肩关节置换术后患者的SSI和人工关节感染(PJI)数据。进行了带有随机效应模型的荟萃分析。结果:共纳入11项研究(29,371例患者和35,323例关节)。主要程序为全髋关节置换术(53.3%),平均随访时间为21.5个月,最短随访时间为12个月。共有2400例(9.5%)报告有术前BCM(15%)或ASB(85%)。 ASB患者中SSI的比例较高(2.3%vs. 1.1%)(p <0.001),并且与SSI风险较高相关(比值比[OR] 2.89; 95%置信区间[CI] 1.36-6.17 ),但只有6例(12.7%)的SSI微生物与尿液培养相关。最后,针对ASB的抗生素治疗并未降低SSI风险(OR = 0.82; 95%CI 0.34-1.97)。结论:无症状菌尿是这些患者中相对普遍的发现,并且与SSI风险较高有关。但是,不良的微生物学相关性表明,ASB可能代表了与细菌感染相关的其他疾病的替代标志。因此,应避免进行系统的尿液分析筛查,而应提倡考虑合并症和既往病史的完整风险评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号